Andrea Bernabeu, PhD, MD, Gynaecologist at Instituto Bernabeu, has received in New York the Young Investigator Award for her work on advanced genetics techniques on chromosome alteration on embryos.
We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Instituto Bernabeu deals with the most complex of cases because it has over 30 years' experience that are a guarantee of expert hands at a leading clinic where each case is given personalised treatment. Wasting time is not an option when we are racing against the clock. When the aim of that race is a pregnancy, it is impossible to recover missed opportunities. If a woman's age and the fact that she is not getting pregnant combine, there is only one possible piece of advice: Put yourself in the very best hands and do not leave what quality reproductive medicine can do for you to chance.
On 24th November, the University of Alicante will hold the V Edition of Patent Rights and Biotechnology Event organised by Magister Lvcentinvs - the centre for Master's Degree education in Industrial and Intellectual Property at the University of Alicante. At the event, university lecturers, lawyers and other experts in the field of biotechnology will cover specific aspects of the legal impact of scientific progress.
A team of researchers at Instituto Bernabeu has completed a prospective randomised clinical trial aimed at understanding if selection of an embryo generated during a cycle of in vitro fertilisation (IVF) is possible when morphological development is observed just once over the days leading up to transfer. The results of the research work will be presented at the national congress organised by the Association for the Study of Reproduction Biology due to be held in Madrid between 15th and 17th November.
Instituto Bernabeu will once again participate in the Association for the Study of Reproduction Biology (ASEBIR) Congress that is due to be held in Madrid between 15th and 17th November. The reproductive medicine clinic will present ten pieces of research work at the congress. Four of these were produced by the Embryology Unit at Instituto Bernabeu; another by the Egg Donation Unit; and the remaining pieces of work were carried out by the clinic's Molecular Biology and Genetics departments.
The Medical Director of Instituto Bernabeu, Dr Rafael Bernabeu, will participate in the 5th edition of the Contraception Congress organised by the Castilla La Mancha Contraception Society due to be held in Albacete on the 10th and 11th November. The Director of the Instituto Bernabeu Group, Dr Rafael Bernabeu, will cover the revolutionary discovery of the uses of anti-mullerian hormone in his speech entitled 'A new paradigm in contraception: AMH and derivatives.'
We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Within the framework of annual support given to university studies, the Rafael Bernabeu Social Welfare Foundation at Instituto Bernabeu has awarded scholarships to six Medicine and Nursing university students. The scholarships have a value of 2,500 euros each.
Instituto Bernabeu will present a study entitled 'Embryo mosaicism and its impact on the results of cycles of in vitro fertilisation (IVF) and associated factors' at the 19th edition of the Congress of the Association for the Study of Reproduction Biology (ASEBIR) due to be held in Madrid between 15th and 17th November.
The clinic has promoted a scientific exchange in which prominent specialists from the Region of Murcia participate in a conference that takes place at the Universidad Politécnica of Cartagena on Friday 1st December.
Instituto Bernabeu will present one of its lines of research work in North America. It will do so at the American Society of Reproductive Medicine Congress (ASRM) due to be held between 28th October and 1st November in San Antonio and the research consists of a clinical trial for improving patient comfort during assisted reproduction treatment.
statistiques de résultatsEn savoir plus
Nos résultats de grossesse sont accrédités par des sociétés de certifications externes.